


DisruPep
Biotechnology Research • Madrid, Community of Madrid, Spain • 1-10 Employees
Company overview
| Headquarters | Avenida del Dr. Arce, 37, Madrid, Madrid 28002, ES |
| Websites | |
| NAICS | 541714 |
| Founded | 2020 |
| Employees | 1-10 |
Key Contact at DisruPep
Ismael San Mauro Martín
CEO
About DisruPep
DisruPep S.L. was born in 2020 as a spanish biotech with technology for the development of peptide-based drugs. DisruPep is a spin-off Technology-Based Company of the Cajal Institute in Madrid within an important laboratory of neuroscience. Cajal Institute take part of the Spanish National Research Council (Spanish: Consejo Superior de Investigaciones Científicas, CSIC) is the largest public institution dedicated to research in Spain and the third largest in Europe. DisruPep was created with the purpose of developing and exploiting as a licensee a drug candidate as a therapy for post-traumatic stress disorder (PTSD): the QBP1 peptide. As well as development of other drugs and products forming a company of high scientific and business interest. Working with optimism to improve the lives of people suffering from PTSD, Type 2 Diabetes, Parkinson's and ALS.
DisruPep revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
DisruPep has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
DisruPep has never raised funding before.
DisruPep Tech Stack
Discover the technologies and tools that power DisruPep's digital infrastructure, from frameworks to analytics platforms.
Hosting
Page builders
JavaScript libraries
Databases
WordPress plugins
Reverse proxies
Programming languages
Font scripts
Blogs
Maps
WordPress themes
JavaScript libraries
Frequently asked questions
4.8
40,000 users



